Very long chain acyl-CoA dehydrogenase deficiency: Successful treatment of acute cardiomyopathy

Biochemical and Molecular Medicine

Volumn 58, Issue 1, 1996, Pages 59-65

  Brown Harrison, Mary Carole ^a   Nada, Mohamed A ^b   Sprecher, Howard ^c   Vianey Saban, Christine ^d   Farquhar Jr , John ^e   Gilladoga, Angela C ^e   Roe, Charles R ^b  

^a Baylor University Medical Center ^*  (United States)

^b BAYLOR UNIVERSITY MEDICAL CENTER   (United States)

^c OHIO STATE UNIVERSITY   (United States)

^d HÔPITAL DEBROUSSE   (France)

^e EASTERN MAINE MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACYL COENZYME A DEHYDROGENASE; ACYLCARNITINE;

AMINO ACID ANALYSIS; ARTICLE; CARDIOMYOPATHY; CASE REPORT; CAUSE OF DEATH; EARLY DIAGNOSIS; ENZYME ACTIVITY; ENZYME DEFICIENCY; FAT INTAKE; FATTY ACID OXIDATION; FEMALE; GAS CHROMATOGRAPHY; HUMAN; HYPOGLYCEMIA; INFANT; MALE; MASS SPECTROMETRY; METABOLIC ACIDOSIS; NEWBORN; PERICARDIAL EFFUSION; PRENATAL DIAGNOSIS; STEATOSIS; TRIACYLGLYCEROL BLOOD LEVEL;

EID: 0030175496     PISSN: 10773150     EISSN: None     Source Type: Journal    
DOI: 10.1006/bmme.1996.0033     Document Type: Article

References (16)

1. 1. Bertrand C, Largilliere C, Zabot MT, Mathieu M, and Vianey-Saban C. Very long chain Acyl-CoA dehydrogenase deficiency: Identification of a new inborn error of mitochondrial fatty acid oxidation in fibroblasts. Biochim Biophys Acta 1180:327-329, 1993.
2. 2. Yamaguchi S, Indo Y, Coates PM, Hashimoto T, and Tanaka K. Identification of very-long-chain acyl-CoA dehydrogenase deficiency. Pediatr Res 34:111-113, 1993.
3. 3. Aoyama T, Uchida Y, Kelley RI, Marble M, Hofman K, Tonsgard JH, Rhead WJ, and Hashimoto T. A novel disease with deficiency of mitochondrial very-long-chain Acyl-CoA dehydrogenase. Biochem Biophys Res Commun 191:1369-1372, 1993.
4. 4. Izai K, Uchida Y, Orii T, Yamamoto S, Hashimoto T. Fatty acid β-oxidation enzymes in rat liver mitochondria II. Purification and properties of very-long-chain Acyl-coenzyme dehydrogenase. J Biol Chem 267:1027-1033, 1992.
5. 5. Roe CR, and Coates PM. Mitochondrial fatty acid oxidation disorders. In The Metabolic and Molecular Basis of Inherited Disease (Scriver CR, Beaudet AL, Sly WS, Valle D, Eds.) New York: McGraw-Hill, 1995, pp 1501-1533.
6. 6. Hale DE, Batshaw ML, Coates PM, Frerman FF, Goodman SI, Singh I, and Stanley CA. Long-chain acyl coenzyme A dehydrogenase deficiency: An inherited cause of non-ketotic hypoglycemia. Pediatr Res 19:666-671, 1985.
7. 7. Aoyama T, Souri M, Ueno I, Kamijo T, Yamaguchi S, Rhead WJ, Tanaka K, and Hashimoto T. Cloning of human very-long-chain acyl-coenzyme A dehydrogenase and molecular characterization of its deficiency in two patients. Am J Human Genet 57:273-283, 1995.
8. 8. Aoyama T, Souri M, Ushikubo S, Kamijo T, Yamaguchi S, Kelley RI, Rhead WJ, Uetake K, Tanaka K, and Hashimoto T. Purification of human very-long-chain acyl-coenzyme A dehydrogenase and characterization of its deficiency in seven patients. J Clin Invest 95:2465-2473, 1995.
9. 9. Hug G, Daugherty C, Vianey-Saban C, Ryan M, Gibbons P, Knilans T, Milatovich AT, Berlin R, Stanley C, Benzing P, Roe C, Hackenberg-Bauer P, Rhead W, Hashimoto T, Leslie N, and Schwartz D. Deficient activity of membrane bound very long chain acyl-CoA dehydrogenase (VLCAD) in twin boys. Pediatr Res 35:36A, 202, 1993. [Abstract]
10. 10. Roe CR, Millington DS, Maltby DA, Bohan TP, Kahler SG, and Chalmers RA. Diagnostic and therapeutic implications of medium chain acylcarnitines in the medium chain acyl-CoA dehydrogenase deficiency. Pediatr Res 19:459-466, 1985.
11. 11. Millington DS, Kodo N, Terada N, Roe D, Chace DH. The analysis of diagnostic markers of genetic disorders in human blood and urine using tandem mass spectrometry with liquid secondary ion mass spectrometry. Int J Mass Spectrum Ion Processes 111:211-228, 1991.
12. 12. Vianey-Saban C, Mousson B, Bertrand C, Stamm D, Dumoulin R, Zabot MT, Divry P, Floret D, and Mathieu M. Carnitine palmitoyl transferase I deficiency presenting as a Reye-like syndrome without hypoglycaemia. Eur J Pediatr 152:334-338, 1993.
13. 13. Bertrand C, Dumoulin R, Divry P, Mathieu M, and Vianey-Saban C. Purification of electron transfer flavoprotein from pig liver mitochondria and its application to the diagnosis of deficiencies of acyl-CoA dehydrogenases in human fibroblasts. Clin Chim Acta 210:75-91, 1992.
14. 14. Nada MA, Chace DH, Sprecher H, and Roe CR. Investigation of β-oxidation intermediates in normal and MCAD-deficient human fibroblasts using tandem mass spectrometry. Biochem Mol Med 54:59-66, 1995.
15. 15. Nada MA, Rhead WJ, Sprecher H, Schulz H, and Roe CR. Evidence of intermediate channeling in mitochondrial β-oxidation. J Biol Chem 270:530-535, 1995.
16. 16. Nada MA, Vianey-Saban C, Roe CR, Ding JH, Mathieu M, Wappner RS, Bialer MG, McGlynn JA, and Mandon G. Prenatal diagnosis of mitochondrial fatty acid oxidation defects. Prenatal Diagn 16:117-124, 1996.